hydroxyurea has been researched along with Cancer of Esophagus in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-two patients with resectable (clinical stage IIa, n = 17; IIb, n = 1; III, n = 14) squamous cell cancer (n = 15) or adenocarcinoma (n = 17) were treated with neoadjuvant chemotherapy (cisplatin, 5-fluorouracil, leukovorin), resection, and postoperative chemoradiotherapy (hydroxyurea, 5-fluorouracil; 50-66 Gy)." | 3.69 | Intensive multimodality therapy for carcinoma of the esophagus and gastroesophageal junction. ( Drinkard, LC; Ferguson, MK; Haraf, DJ; Hoffman, PC; Reeder, LB; Vokes, EE, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Tang, Q | 1 |
| Wu, L | 1 |
| Xu, M | 1 |
| Yan, D | 1 |
| Shao, J | 1 |
| Yan, S | 1 |
| Sun, J | 1 |
| Okumura, H | 1 |
| Yearsley, M | 1 |
| Frankel, W | 1 |
| Fong, LY | 1 |
| Druck, T | 1 |
| Huebner, K | 1 |
| Victorzon, M | 1 |
| Tolonen, P | 1 |
| Kohonen, M | 1 |
| Salmo, M | 1 |
| Chen, X | 1 |
| Wang, S | 1 |
| Wu, N | 1 |
| Sood, S | 1 |
| Wang, P | 1 |
| Jin, Z | 1 |
| Beer, DG | 1 |
| Giordano, TJ | 1 |
| Lin, Y | 1 |
| Shih, WC | 1 |
| Lubet, RA | 1 |
| Yang, CS | 1 |
| Ferguson, MK | 1 |
| Reeder, LB | 1 |
| Hoffman, PC | 1 |
| Haraf, DJ | 1 |
| Drinkard, LC | 1 |
| Vokes, EE | 1 |
| Ganem, G | 1 |
| Dubray, B | 1 |
| Raoul, Y | 1 |
| Colin, P | 1 |
| Bardet, E | 1 |
| Douillard, JY | 1 |
| Goudier, MJ | 1 |
| Hennequin, C | 1 |
| Walter, S | 1 |
| Michel-Langlet, P | 1 |
| Martin, P | 1 |
| Maron, D | 1 |
| Morvan, F | 1 |
| Andolenko, P | 1 |
| Extra, JM | 1 |
| Stephens, FO | 1 |
| Hussey, DH | 1 |
| Samuels, ML | 1 |
1 trial available for hydroxyurea and Cancer of Esophagus
| Article | Year |
|---|---|
Concomitant chemoradiotherapy followed, where feasible, by surgery for cancer of the esophagus.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 1997 |
7 other studies available for hydroxyurea and Cancer of Esophagus
| Article | Year |
|---|---|
Osalmid, a Novel Identified RRM2 Inhibitor, Enhances Radiosensitivity of Esophageal Cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cellula | 2020 |
Nit1 and Fhit tumor suppressor activities are additive.
Topics: Acid Anhydride Hydrolases; Aminohydrolases; Animals; Cells, Cultured; Checkpoint Kinase 2; Disease S | 2009 |
Outcome of surgery for oesophageal carcinoma in a low volume centre, with and without preoperative chemoradiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cisplatin; Combined Modalit | 2004 |
Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis.
Topics: Adenocarcinoma; Anastomosis, Surgical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonat | 2004 |
Intensive multimodality therapy for carcinoma of the esophagus and gastroesophageal junction.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 1995 |
Combined chemotherapy, radiotherapy, and surgery in the treatment of advanced but localized solid malignant tumours.
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cystadenocarcinoma; Drug Th | 1974 |
Combined hydroxyurea and radiotherapy: a new dosage schedule.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Head; Head and Neck Neoplasms; | 1972 |